U01DA052713
Cooperative Agreement
Overview
Grant Description
Charting the 3D epigenome in human brain development and diseases.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
San Francisco,
California
94143
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 428% from $636,375 to $3,361,246.
San Francisco Regents Of The University Of California was awarded
Charting the 3D epigenome in human brain development and diseases
Cooperative Agreement U01DA052713
worth $3,361,246
from the National Institute of Allergy and Infectious Diseases in September 2020 with work to be completed primarily in San Francisco California United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 12/17/24
Period of Performance
9/30/20
Start Date
8/31/25
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01DA052713
Transaction History
Modifications to U01DA052713
Additional Detail
Award ID FAIN
U01DA052713
SAI Number
U01DA052713-2659496921
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
KMH5K9V7S518
Awardee CAGE
4B560
Performance District
CA-11
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,909,125 | 100% |
Modified: 12/17/24